Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Anorexia Nervosa Pipeline Insight Report, 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 13 Dec 18

The "Anorexia Nervosa - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Anorexia Nervosa - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anorexia Nervosa development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Anorexia Nervosa pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Anorexia Nervosa Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Anorexia Nervosa

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • GlaxoSmithKline
  • Novo Nordisk A/S
  • Cannabics Pharmaceuticals Inc.

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/3gm9qn/anorexia_nervosa?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005877/en/

Business Wire
www.businesswire.com

Last updated on: 13/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.